mobile menu icon
Travers Smith Logo

Pharmaceuticals & Medical Devices

Sunday, 25 August 2019

With an ever increasing amount of regulatory scrutiny together with other market pressures, these are challenging times for many pharmaceutical and medical device businesses.

That said, this remains a vibrant and exciting sector for those able to find the opportunities. Our integrated cross-departmental team, which brings together a number of lawyers recognised as leaders in their field, has not only a strong transactional pedigree, but also expertise in providing robust, pragmatic and realistic advice on a range of EU and UK regulatory controls.

Our services:

  • Product liability and safety
  • Supply chain management
  • Compliance and permitting
  • Litigation and regulatory defence
  • Crisis and reputational risk
  • Joint ventures
  • Outsourcing
  • Supply and distribution contracts
  • Data protection
  • Employment disputes and strategic advice
  • Corporate finance and M&A
  • Corporate advisory
  • Real estate


  • Silverfleet Capital on their investment in Aesica Pharmaceuticals Limited
  • Major pharmaceuticals supplier on compliance with UK and EU pharmaceutical controls and a potential regulatory notification and product recall
  • UK medical devices manufacturer on a range of permitting and operational compliance issues
  • 2IL Orthopaedics Limited on its successful recommended cash offer to acquire the entire issued and to be issued share capital of main market listed Corin Group plc. (designer, manufacturer and distributor of orthopaedics) including specific advice on product and regulatory issues
  • Benchmark Holdings plc, an international veterinary drug, technical publishing and sustainability science business, on its AIM IPO and institutional placing worth £45.1 million
  • Investec Bank plc on the £60m rights issue by Dechra Pharmaceuticals plc
  • Bosch on the acquisition of two specialist pharmaceutical businesses via a combined share and asset deal